Ionis Pharmaceuticals, Inc.
ANTISENSE COMPOUNDS AND USES THEREOF

Last updated:

Abstract:

The present invention provides compounds comprising oligonucleotides complementary to a pyruvate kinase M transcript. Certain such compounds are useful for hybridizing to a pyruvate kinase M transcript, including but not limited to a pyruvate kinase M transcript in a cell. In certain embodiments, such hybridization results in modulation of splicing of the pyruvate kinase M transcript. In certain embodiments, such compounds are used to treat one or more symptoms associated with cancer.

Status:
Application
Type:

Utility

Filling date:

2 Oct 2018

Issue date:

15 Aug 2019